Complement 5a Receptor Antagonist [EPC]

This page covers all Complement 5a Receptor Antagonist [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting C5a anaphylatoxin chemotactic receptor 1.

Targets

C5a anaphylatoxin chemotactic receptor 1

Marketed (1)

• Tavneos · Chemocentryx · Rare Disease · 400
  Tavneos blocks the action of a chemical called C5a, which is involved in the body's inflammatory response.